968 related articles for article (PubMed ID: 10947976)
1. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
[TBL] [Abstract][Full Text] [Related]
2. Cloning and expression of rat pancreatic beta-cell malonyl-CoA decarboxylase.
Voilley N; Roduit R; Vicaretti R; Bonny C; Waeber G; Dyck JR; Lopaschuk GD; Prentki M
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):213-7. PubMed ID: 10229677
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
[TBL] [Abstract][Full Text] [Related]
4. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
[TBL] [Abstract][Full Text] [Related]
5. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
6. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.
Bouzakri K; Austin R; Rune A; Lassman ME; Garcia-Roves PM; Berger JP; Krook A; Chibalin AV; Zhang BB; Zierath JR
Diabetes; 2008 Jun; 57(6):1508-16. PubMed ID: 18314420
[TBL] [Abstract][Full Text] [Related]
7. Malonyl-CoA decarboxylase is present in the cytosolic, mitochondrial and peroxisomal compartments of rat hepatocytes.
Joly E; Bendayan M; Roduit R; Saha AK; Ruderman NB; Prentki M
FEBS Lett; 2005 Dec; 579(29):6581-6. PubMed ID: 16298369
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific regulation of malonyl-CoA decarboxylase activity in OLETF rats.
Kim HJ; Zhao ZS; Lee YJ; Shim WS; Kim SK; Ahn CW; Park CW; Lee HC; Cha BS
Diabetes Obes Metab; 2006 Mar; 8(2):175-83. PubMed ID: 16448521
[TBL] [Abstract][Full Text] [Related]
9. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I.
Zhu H; Shi J; de Vries Y; Arvidson DN; Cregg JM; Woldegiorgis G
Arch Biochem Biophys; 1997 Nov; 347(1):53-61. PubMed ID: 9344464
[TBL] [Abstract][Full Text] [Related]
10. Human liver-specific very-long-chain acyl-coenzyme A synthetase: cDNA cloning and characterization of a second enzymatically active protein.
Steinberg SJ; Wang SJ; McGuinness MC; Watkins PA
Mol Genet Metab; 1999 Sep; 68(1):32-42. PubMed ID: 10479480
[TBL] [Abstract][Full Text] [Related]
11. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
Zhou W; Tu Y; Simpson PJ; Kuhajda FP
Oncogene; 2009 Aug; 28(33):2979-87. PubMed ID: 19543323
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation.
Dyck JR; Barr AJ; Barr RL; Kolattukudy PE; Lopaschuk GD
Am J Physiol; 1998 Dec; 275(6):H2122-9. PubMed ID: 9843812
[TBL] [Abstract][Full Text] [Related]
13. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line.
Habinowski SA; Hirshman M; Sakamoto K; Kemp BE; Gould SJ; Goodyear LJ; Witters LA
Arch Biochem Biophys; 2001 Dec; 396(1):71-9. PubMed ID: 11716464
[TBL] [Abstract][Full Text] [Related]
14. Abundant expression of translation initiation factor EIF-4E in post-meiotic germ cells of the rat testis.
Miyagi Y; Kerr S; Sugiyama A; Asai A; Shibuya M; Fujimoto H; Kuchino Y
Lab Invest; 1995 Dec; 73(6):890-8. PubMed ID: 8558852
[TBL] [Abstract][Full Text] [Related]
15. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors.
Cheng JF; Chen M; Wallace D; Tith S; Haramura M; Liu B; Mak CC; Arrhenius T; Reily S; Brown S; Thorn V; Harmon C; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
J Med Chem; 2006 Mar; 49(5):1517-25. PubMed ID: 16509570
[TBL] [Abstract][Full Text] [Related]
17. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
Lane MD; Wolfgang M; Cha SH; Dai Y
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
19. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
20. MCD encodes peroxisomal and cytoplasmic forms of malonyl-CoA decarboxylase and is mutated in malonyl-CoA decarboxylase deficiency.
Sacksteder KA; Morrell JC; Wanders RJ; Matalon R; Gould SJ
J Biol Chem; 1999 Aug; 274(35):24461-8. PubMed ID: 10455107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]